Sign In
Buy STEV
$0.0001
+0 (+0%)
At Close: Jun 03, 2026
Stevia (OTCMKTS:STEV) Share Price Passes Above 200 Day Moving Average – Should You Sell?
02:19am, Friday, 27'th Mar 2026
Stevia Corp. (OTCMKTS:STEV - Get Free Report) passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $0.00 and traded as high as
Stevia (OTCMKTS:STEV) Stock Price Crosses Above 200-Day Moving Average – What’s Next?
03:17am, Wednesday, 18'th Mar 2026
Stevia Corp. (OTCMKTS:STEV - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.00 and traded as high as $0
Stevia (OTCMKTS:STEV) Stock Price Crosses Above 200-Day Moving Average – What’s Next?
04:31am, Tuesday, 10'th Mar 2026
Stevia Corp. (OTCMKTS:STEV - Get Free Report) shares passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0019. St
Stevia (OTCMKTS:STEV) Shares Cross Above 200 Day Moving Average – Time to Sell?
04:17am, Thursday, 19'th Feb 2026
Stevia Corp. (OTCMKTS:STEV - Get Free Report) shares passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0013.
ST Boosts EV Efficiency With STEV High-Voltage Contactor Series
10:20am, Thursday, 15'th Jan 2026
Sensata launches STEV high-voltage contactors to support scalable, safer BEV and PHEV power management as OEMs face stricter safety and efficiency demands.
Stevia (OTCMKTS:STEV) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?
03:54am, Thursday, 08'th Jan 2026
Stevia Corp. (OTCMKTS:STEV - Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0015. Stevi
Stevia Corp. Issues Shareholder Letter
06:00am, Thursday, 30'th Sep 2021
Letter Highlights Elimination of Toxic Debt, Decreased Payables, and Plans to Use Board Member and Practicing Neurologist Dr. Jerry Smartt Jr. in a More Active Role NEW YORK, NY / ACCESSWIRE / Septemb
